Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-04T22:01:17.418Z Has data issue: false hasContentIssue false

Emotional symptomatology in obese patients treated with fenfluramine and dextroamphetamine

Published online by Cambridge University Press:  09 July 2009

Karl Rickels*
Affiliation:
Departments of Psychiatry, University of Pennsylvania and Philadelphia General Hospital, Philadelphia, Pa.
Peter Hesbacher
Affiliation:
Departments of Psychiatry, University of Pennsylvania and Philadelphia General Hospital, Philadelphia, Pa.
Ellen Fisher
Affiliation:
Departments of Psychiatry, University of Pennsylvania and Philadelphia General Hospital, Philadelphia, Pa.
Milton M. Perloff
Affiliation:
Departments of Psychiatry, University of Pennsylvania and Philadelphia General Hospital, Philadelphia, Pa.
Howard Rosenfeld
Affiliation:
Departments of Psychiatry, University of Pennsylvania and Philadelphia General Hospital, Philadelphia, Pa.
*
1Address for correspondence: Professor Karl Rickels, 203 Piersol Building, 3600 Spruce Street, Philadelphia, Pa. 19104, USA.

Synopsis

Emotional symptomatology data on 78 obese females treated for 3 weeks with fenfluramine, dextroamphetamine, or placebo were evaluated. These obese females were shown to be considerably less emotionally disturbed than neurotic females, and similar in emotional symptomatology to other females seeing physicians for nonpsychiatric complaints. Even within these marginally symptomatic patients, fenfluramine and dextroamphetamine were significantly more effective than placebo in reducing anxious, depressive, and anxious-depressive symptomatology. Fenfluramine was particularly effective in alleviating anxiety in patients who were initially higher in anxiety. Most important, fenfluramine produced significantly greater weight loss than dextroamphetamine in patients with higher levels of anxiety and depression, while dextroamphetamine was an especially effective anorexic in low anxious patients. Differences in initial anxiety and depression, even within relatively normal patients, may well affect results obtained with fenfluramine and dextroamphetamine in the short-term treatment of obesity.

Type
Research Article
Copyright
Copyright © Cambridge University Press 1977

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Clyde, D. J. (1963). Manual for the Clyde Mood Scale. Biometric Laboratory, University of Miami: Coral Gables, Florida.Google Scholar
Derogatis, L. R., Lipman, R. S., Rickels, K., Uhlenhuth, E. H. & Covi, L. (1974). The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behavioural Science 19, 115.CrossRefGoogle ScholarPubMed
Gaind, R. (1969). Fenfluramine (Ponderax) in the treatment of obese psychiatric outpatients. British Journal of Psychiatry 115, 963964.CrossRefGoogle Scholar
Hesbacher, P., Rickels, K., Rial, W. Y., Segal, A. & Zamostien, B. (in press). Psychotropic drug prescription in family practice. Comprehensive Psychiatry.Google Scholar
Imlah, N. W. (1970). Unusual effect of fenfluaramine (correspondence). British Medical Journal ii, 178179.CrossRefGoogle Scholar
McCance, C. (1961). Psychiatric factors in obesity. Dissertation in psychological medicine, University of London.Google Scholar
Raich, W. A., Rickels, K. & Raab, E. (1966). A double-blind evaluation of fenfluramine in anxious somatizing neurotic medical clinic patients. Current Therapeutic Research 8, 3133.Google ScholarPubMed
Rickels, K. & Howard, K. (1970). The Physician Questionnaire: a useful tool in psychiatric drug research. Psychopharmacologia (Berlin) 17, 338344.Google Scholar
Rickels, K., Garcia, C. R. & Fisher, E. (1971). A measure of emotional distress in private gynecologic practice. Obstetrical Gynecology 38, 139146.Google ScholarPubMed
Silverstone, J. T. (1968). Psychosocial aspects of obesity. Proceedings of the Royal Society of Medicine 61, 371375.CrossRefGoogle ScholarPubMed
Stunkard, A., Rickels, K. & Hesbacher, P. (1973). Fenfluramine in the treatment of obesity. Lancet i, 503505.CrossRefGoogle Scholar
Uhlenhuth, E. H., Lipman, R. S., Balter, M. B. & Stern, M. (1974). Symptom intensity and life stress in the city. Archives of General Psychiatry 31, 759764.CrossRefGoogle ScholarPubMed